ANDREA GRAY: Open Payments
NPI 1316360803 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 78 payments from 13 companies in 2025. Trend: 2023 $1,509 · 2024 $1,784 · 2025 $1,395
Food & beverage: $1,311Education: $84
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $402 |
| ABBVIE INC. | 20 | $273 |
| Janssen Biotech, Inc. | 6 | $198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $161 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Ardelyx, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $60 |
| Madrigal Pharmaceuticals | 3 | $59 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
Products named: XIFAXAN, TREMFYA, RINVOQ, LINZESS, ENTYVIO, DUPIXENT, EOHILIA, IBSRELA.
Industry payments across MO — which companies pay providers there.
